Sanofi (SYN) CEO Paul Hudson Hosts 43rd Annual J.P. Morgan Healthcare (Transcript)
Sanofi (SYN) 43rd Annual J.P. Morgan Healthcare January 14, 2025 12:45 PM ETCompany ParticipantsPaul Hudson - Chief Executive OfficerFrancois-Xavier Roger ...
pharmaphorum4d
BMS files legal challenge to HHS' 340B rebate decision
The 340B requirement has long been a bone of contention ... Last year, for example, a federal appeals court sided with Sanofi, AstraZeneca, and Novo Nordisk in a dispute claiming that recipients ...
The Pharma Letter6h
Novartis sues US health agency over drug rebate model
Novartis sues HHS over rejection of a proposed 340B rebate model, arguing it enhances transparency and compliance while ...
NorthJersey.com3d
New Jersey hospitals exploit 340B at the expense of patients. We have to fix it | Opinion
The 340B program, once a lifeline for underserved communities, has become a case study in crony capitalism. Designed to help hospitals serving low-income patients by offering discounted ...
Yahoo Finance4d
Sanofi to increase competition in atopic dermatitis market after Dupixent success
Sanofi's participation at the JP Morgan 43rd Annual Healthcare Conference on 14 January 2025 was marked by a comprehensive overview of the company's position in 2024 and its strategic vision for t ...
FiercePharma6d
JPM25: GSK, Sanofi CEOs welcome 'transparency' in response to anti-vaccine movement in US
Kennedy Jr. to run the Department of Health and Human Services. How do Sanofi CEO Paul Hudson and GSK CEO Emma Walmsley—who lead two of the top vaccine companies in the world—feel about the ...
Becker's Hospital Review5d
340B contractor boosts profits while driving up patient costs: Report
Apexus, a key contractor for the 340B drug pricing program, has come under scrutiny for profiting off its expanding role in the program, which was initially designed to help safety-net hospitals ...
Becker's Hospital Review2d
Novartis sues HHS over 340B pricing model
Pharmaceutical company Novartis has filed a lawsuit against the HHS over the way drugs are priced under the 340B program. The company is challenging the "product replenishment model," which ...
pharmaphorum1d
Sanofi refocuses to tackle key business challenges
Sanofi is reorganising its business units from seven to five in a bid to streamline its operations and ensure the success of its ambitious product launch plans. The revamp is the first major ...
Reuters23h
United States
Donald Trump will be sworn in today, ushering in another turbulent four-year term with promises to push the limits of executive power, deport millions of immigrants, secure retribution against his ...
Fox News6d
Former Cowboys star Jason Witten floated as potential head coach replacement following Mike McCarthy's exit
The Dallas Cowboys' search for the franchise's next head coach is underway. On Monday, longtime Cowboys owner and general manager Jerry Jones confirmed that the organization and coach Mike ...